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FACT SHEET          CRYPTOSPORIDIOSIS 
For Healthcare Providers                            (Commonly referred to as “Crypto”)            
 
What is Cryptosporidiosis?   
Cryptosporidiosis is a parasitic infection caused by the protozoan Cryptosporidium. Cryptosporidium 
parvum and Cryptosporidium hominis, are the most prevalent species causing disease in humans.  Once 
an animal or person is infected, the parasite lives in the intestine and passes in the stool. The infectious 
oocyst of the parasite is protected by an outer shell that allows it to survive outside the body for long 
periods of time and makes it very resistant to chlorine-based disinfectants.    
 
What is the clinical description of Cryptosporidiosis? 
The most common symptom of cryptosporidiosis is profuse and watery diarrhea.  Other signs and 
symptoms include weight loss, stomach cramps, nausea, vomiting, and low-grade fever.  Although 
infection is usually limited to the gastrointestinal tract, Cryptosporidium infections could possibly affect 
other areas of the digestive or the respiratory tract. Asymptomatic infections are common and often 
serve as a source of infection for others.  Symptoms often wax and wane, but remit in fewer than 30 
days. In most immunocompetent people (including children), the illness is self-limited, lasting 1 to 20 
days (average 10 days).  Immunodeficiency, especially in HIV infection, is associated with an inability to 
clear the parasite, and the disease may have a prolonged and fulminant clinical course, leading to death. 
 
How is Cryptosporidium transmitted? 
In order for infection to occur, the susceptible host must ingest water or other materials contaminated 
with the Cryptosporidium oocysts, referred to as fecal-oral transmission.  Important routes of 
transmission include person-to-person, animal-to-person, foodborne, and waterborne (drinking and 
recreational).   
 
Who is most at risk for Cryptosporidiosis?   
Anyone can get cryptosporidiosis.  People who are most likely to become infected with Cryptosporidium 
include:  Child care workers and diaper-aged children who attend child care centers; Parents of infected 
children; International travelers; Swimmers who swallow water while swimming in swimming pools, lakes, 
rivers, ponds, and streams; and backpackers, hikers, and campers who drink unfiltered, untreated water.  
 
How long is Cryptosporidiosis communicable? 
The disease is communicable for as long as the infected person excretes Cryptosporidium oocysts. 
Excretion generally begins at the onset of symptoms. Oocysts continue to be excreted in the stool for 
several weeks after symptoms subside, and they may remain infective outside the body for 2 - 6 months 
in a moist environment. 
 
What laboratory tests are used to diagnose Cryptosporidium? 
Diagnosis is generally made by the microscopic identification of oocysts in fecal smears (Ova and Parasite 
Exam).  Organisms can also be identified in intestinal biopsy tissue.  For microscopic examination, there 
are three techniques available: wet mounts, stained smears (e.g., modified acid fast stain), and 
immunofluorescent staining. In addition, new and more sensitive enzyme immunoassay (EIA) tests have 
recently become available.  EIA kit sensitivities and specificities reportedly range from 93 to 100 percent 
when used in a clinical setting.  Since the infectious oocysts are excreted from the body intermittently, at 
least two stool samples should be examined before the test can be considered negative and 
Cryptosporidium is ruled out as the diagnosis. 
The State Hygienic Laboratory uses the routine Ova and Parasite (O & P) microscopic exam and a special 
acid fast stain for Cryptosporidium if requested.   
 
Is there a treatment for diarrhea caused by Cryptosporidium? 
Yes, FDA licensed Nitazoxanide (Alinia®, Romark Laboratories, Tampa, FL, USA) for persons with healthy 
immune systems > 1 year of age.   
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What about patients with compromised immune systems? 
Nitazoxanide has been approved for treatment of diarrhea caused by Cryptosporidium in people with 
healthy immune systems.  It is currently not approved to treat immunodeficient persons.   
 
What is the dosage used for Nitazoxanide? 
 
Immunocompetent Persons 
Adult dosage 500 mg BID x 3 days 
Pediatric dosage 
1-3 years; 100 mg BID x 3 days 
4-11 years; 200 mg BID x 3 days 
 
Nitazoxanide oral suspension (100 mg/5 ml; patients >1 year of age) and Nitazoxanide tablets (500 mg; 
patients >12 years of age) are indicated for the treatment of diarrhea caused by Cryptosporidium.   
 
What is the efficacy of Nitazoxanide? 
Clinical cure (resolution of diarrhea) occurs in 72-88 percent of patients. Parasitologic cure (no 
Cryptosporidium detected in the stool) occurs in 60-75 percent. It may take up to 5 days for diarrhea to 
resolve in approximately 80 percent of patients.   
 
What should I tell my patients with cryptosporidiosis? 
 All infected persons, including those who have completed treatment, should not swim for two 
weeks after resolution of symptoms.  Cryptosporidium oocysts are chlorine-resistant.  It is critical 
that this recommendation is followed to prevent the spread of cryptosporidiosis through public 
swimming pools and other aquatic venues.   
 Wash hands with soap and water after using the toilet, changing diapers, and before eating or 
preparing food.   
 Avoid fecal exposure during sexual activity. 
 
Is my patient required to have two negative stools before returning to school, child 
care, or work settings? 
IDPH does not require persons with confirmed cryptosporidiosis to provide two negative stools to return 
to school, child care, or work settings. Persons with cryptosporidiosis should stay home until diarrhea and 
vomiting resolve.     
 
For more information: 
 CDC: www.cdc.gov/parasites/crypto/index.html  
 CDC: www.cdc.gov/parasites/crypto/health_professionals/tx.html  
 
 
 
 
